Congress Trades in Exact Sciences Corporation - Common Stock (EXAS)
4 members of Congress have disclosed trading EXAS.
Total trades
15
Purchases
9
Sales
6
Members
4
Est. volume
$187,000
Last traded
Mar 24, 2026
4 members of Congress have disclosed trading Exact Sciences Corporation - Common Stock (EXAS), with 15 transactions in total — 9 purchases and 6 sales worth an estimated $187,000 at range midpoints, leaning toward buying. The most active EXAS trader is Kevin Hern (7 disclosures). The most recent disclosed EXAS trade was on Mar 24, 2026.
Every disclosed EXAS trade
| Disclosed | Politician | Type | Amount | Traded | |
|---|---|---|---|---|---|
| Mar 31, 2026 | Kevin Hern R | Sale | $1,001 - $15,000 | Mar 24, 2026 | filing ↗ |
| Jun 5, 2024 | Josh Gottheimer D | Sale | $1,001 - $15,000 | May 10, 2024 | filing ↗ |
| Jan 3, 2024 | Kevin Hern R | Sale | $1,001 - $15,000 | Jan 2, 2024 | filing ↗ |
| Nov 7, 2023 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Oct 16, 2023 | filing ↗ |
| Feb 6, 2023 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Jan 20, 2023 | filing ↗ |
| Feb 1, 2023 | Kevin Hern R | Sale | $1,001 - $15,000 | Jan 31, 2023 | filing ↗ |
| May 17, 2022 | Kevin Hern R | Sale | $1,001 - $15,000 | May 16, 2022 | filing ↗ |
| May 21, 2021 | Kevin Hern R | Purchase | $1,001 - $15,000 | May 20, 2021 | filing ↗ |
| May 21, 2021 | Kevin Hern R | Purchase | $50,001 - $100,000 | May 20, 2021 | filing ↗ |
| Nov 4, 2020 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Oct 26, 2020 | filing ↗ |
| Jul 28, 2020 | Kevin Hern R | Purchase | $1,001 - $15,000 | Jul 27, 2020 | filing ↗ |
| Apr 15, 2020 | Gilbert Cisneros D | Purchase | $1,001 - $15,000 | Mar 16, 2020 | filing ↗ |
| Feb 4, 2020 | Josh Gottheimer D | Purchase | $1,001 - $15,000 | Jan 22, 2020 | filing ↗ |
| Jun 30, 2019 | Donna Shalala | Sale | $1,001 - $15,000 | Jun 24, 2019 | filing ↗ |
| Jun 30, 2019 | Donna Shalala | Purchase | $1,001 - $15,000 | Jun 19, 2019 | filing ↗ |
Most active EXAS traders in Congress
Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.